RE: Runners and riders22 Apr 2021 08:24
There are already promising drugs in human trials, including a repurposed treatment for flu, and new drugs. Professor Peter Horby, who helps lead the Recovery trial, said the new task force was necessary as it would be able to pick up early-stage products and accelerate them.
“It's a challenging market, so that the economics of developing these kinds of drugs are not great, which is why it needs public investment,” he said.